PRNP and colorectal cancer: On the other hand, PrPC overexpression was reported to induce resistance to adriamycin, vincristine, etoposide, 5-FU and cisplatin in SGC7901 gastric cancer cells [54] and resistance to TNFα [30] or adriamycin [25] in LS174 colorectal cancer cells.